Technical Analysis for SEPN - Septerna, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Outside Day | Range Expansion | -2.36% | |
| Gapped Up | Strength | -2.36% | |
| Up 3 Days in a Row | Strength | -9.21% | |
| Gapped Down | Weakness | -9.21% | |
| Hot IPO Pullback | Bullish Swing Setup | -2.49% | |
| Hot IPO Pullback | Bullish Swing Setup | -1.83% | |
| Down 3 Days in a Row | Weakness | -1.83% | |
| Down 4 Days in a Row | Weakness | -1.83% | |
| Down 5 Days in a Row | Weakness | -1.83% | |
| Hot IPO Pullback | Bullish Swing Setup | -5.34% |
| Alert | Time |
|---|---|
| Down 2 % | 11 minutes ago |
| Down 1% | 11 minutes ago |
| 60 Minute Opening Range Breakdown | about 2 hours ago |
| Up 3% | about 4 hours ago |
| Up 2% | about 4 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Drug Discovery Inflammation Metabolic Disease Endocrinology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Drug Discovery Inflammation Metabolic Disease Endocrinology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.34 |
| 52 Week Low | 18.62 |
| Average Volume | 201,079 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 23.93 |
| Average True Range | 1.98 |
| RSI (14) | 51.92 |
| ADX | 0.0 |
| +DI | 19.41 |
| -DI | 20.28 |
| Chandelier Exit (Long, 3 ATRs) | 20.39 |
| Chandelier Exit (Short, 3 ATRs) | 24.57 |
| Upper Bollinger Bands | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | 0.08 |
| MACD Signal Line | 0.09 |
| MACD Histogram | -0.0114 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 27.66 | ||||
| Resistance 3 (R3) | 28.03 | 26.67 | 26.80 | ||
| Resistance 2 (R2) | 26.67 | 25.36 | 26.49 | 26.51 | |
| Resistance 1 (R1) | 24.59 | 24.55 | 23.91 | 24.22 | 26.23 |
| Pivot Point | 23.23 | 23.23 | 22.90 | 23.05 | 23.23 |
| Support 1 (S1) | 21.15 | 21.92 | 20.47 | 20.78 | 18.77 |
| Support 2 (S2) | 19.79 | 21.11 | 19.61 | 18.49 | |
| Support 3 (S3) | 17.71 | 19.79 | 18.20 | ||
| Support 4 (S4) | 17.34 |
